Answers are grounded in this paper and cite their sources.
The skin is the first host tissue that the tick mouthparts, tick saliva, and a tick-borne pathogen contact during feeding. Tick salivary glands have evolved a complex and sophisticated pharmacological arsenal, consisting of bioactive molecules, to assist blood feeding and pathogen transmission. In this work, persulcatin, a multifunctional molecule that targets keratinocyte function and hemostasis, was identified from Ixodes persulcatus female ticks. The recombinant persulcatin was expressed and purified and is a 25 kDa acidic protein with two Kunitz-type domains. Persulcatin is a classical tight-binding competitive inhibitor of proteases, targeting plasmin ( K i : 28 nM) and thrombin ( K i : 115 nM). It blocks plasmin generation on keratinocytes and inhibits their migration, matrix protein degradation, down-regulates MMP-2 and -9, and causes a delay in blood coagulation, endothelial cell activation, and thrombin-induced fibrinocoagulation. It interacts with exosite I of thrombin and reduces thrombin-induced endothelial cell permeability by inhibiting VE-cadherin disruption. The multifaceted roles of persulcatin as an inhibitor and modulator within the plasminogen-plasmin system and thrombin not only unveils further insights into the intricate mechanisms governing wound healing but also provides a fresh perspective on the intricate interactions between ticks and their host organisms.
No takes yet. Share an insight, caveat, or question.
Oliveira et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: